Improving access to healthcare in remote communities

LEARN MORE

Welcome to the global
corporate site for Takeda.

If you are looking for specific information,
please visit our country/region website. 

 

 

 

 

 

SELECT A COUNTRY OR REGION SITE

FY2020 Q1 Financial Results Highlights
LEARN MORE

Exploring New Paths in Narcolepsy
LEARN MORE

Please wait...

Topics

Partner with our Global CSR Program
LEARN MORE

Leader Driving Change: Sumie Ishii, Chairperson, Japanese Organization for International Cooperation in Family Planning (JOICFP)
LEARN MORE

 COVID-19 Information Center
LEARN MORE

Quarterly Announcements FY 2020 Q1 Results
LEARN MORE

Information

FY2020 Q1 Financial Results Announcement (3:00pm JST on July 31st, 2020)
Q1 Results Conference Call (Presentation & Q&A) : 6:30pm-7:30pm JST
Alternative Timezone Conference Call (Q&A only): 10:00pm-11:00pm JST

Information for US patients regarding the NATPARA recall in the US.
NATPARA is still available in markets outside of the US.

Offer for Shire plc

ADS Helpline

Copyright 1995-2020 Takeda Pharmaceutical Company Limited. All rights reserved.